1187325

GSK LLC (GlaxoSmithKline) — FEI 3006810568

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 24, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Collegeville, PA (United States)

Additional Details

Sponsor, Contract Research Organization